The antibacterial activities along with a report on the selective COX-2 inhibitory activity of limacusine (2) support and validate the traditional use of P. ophthalmicus in treating conjunctivitis and other related bacterial infections. This evidence concerns the gene PTGS2 and conjunctivitis.